Skip to main content

Advertisement

Log in

Update in HIV Medicine for the Generalist

  • Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes. 2004;11(SUPPL. 1):24A–35A.

    PubMed  Google Scholar 

  2. Mosca JD, Bednarik DP, Raj NBK. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature. 1987;325:67–70.

    Article  PubMed  CAS  Google Scholar 

  3. Kucera LS, Leake E, Iyer N, Raben D, Myrvik QN. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses. 1990;6:641–647.

    Article  PubMed  CAS  Google Scholar 

  4. Diaz J-J, Duc Dodon M, Schaerer-Uthurralt N, et al. Post-transcriptional transactivation of human retroviral envelope glycoprotein expression by herpes simplex virus Us11 protein. Nature. 1996;379:273–277.

    Article  PubMed  CAS  Google Scholar 

  5. Heng MCY, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet. 1994;343:255–258.

    Article  PubMed  CAS  Google Scholar 

  6. Baeten JM, McClelland RS, Corey L, et al. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial. J Infect Dis. 2004;189(8):1466–1471 [cited 1 June 2010].

    Article  PubMed  CAS  Google Scholar 

  7. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. J Am Med Assoc. 1998;280:61–66.

    Article  CAS  Google Scholar 

  8. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002;186:1718–1725.

    Article  PubMed  Google Scholar 

  9. Mbopi-Keou F, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in african women: opportunities for intervention. J Infect Dis. 2000;182:1090–1096.

    Article  PubMed  CAS  Google Scholar 

  10. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357:1149–1153.

    Article  PubMed  CAS  Google Scholar 

  11. Delany S, Mlaba N, Clayton T, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009;23:461–469.

    Article  PubMed  CAS  Google Scholar 

  12. Dunne EF, Whitehead S, Sternberg M, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr. 2008;49:77–83.

    Article  PubMed  CAS  Google Scholar 

  13. Nagot N, Ouédraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med. 2007;356:790–799.

    Article  PubMed  CAS  Google Scholar 

  14. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007;196:1500–1508.

    Article  PubMed  CAS  Google Scholar 

  15. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427–439.

    Article  PubMed  CAS  Google Scholar 

  16. WHO/UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. 2007. Available at: http://data.unaids.org/pub/Report/2007/mc_recommendations_en.pdf [cited 1 June 2010].

  17. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2:1112–1122.

    Article  Google Scholar 

  18. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–656.

    Article  PubMed  Google Scholar 

  19. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–666.

    Article  PubMed  Google Scholar 

  20. Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009;374:229–237.

    Article  PubMed  Google Scholar 

  21. Joint United Nations Programme on HIV/AIDS. UNAIDS fact sheet: Sub-saharan Africa. 2007.

  22. Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359:463–472.

    Article  PubMed  Google Scholar 

  23. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209–2220.

    Article  PubMed  CAS  Google Scholar 

  24. Bokhour BG, Solomon JL, Knapp H, Asch SM, Gifford AL. Barriers and facilitators to routine HIV testing in VA primary care. J Gen Intern Med. 2009;24:1109–1114.

    Article  PubMed  Google Scholar 

  25. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR.Recommendations and reports: Morbidity and mortality weekly report.Recommendations and reports/Centers for Disease Control. 2006;55:1-17. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed 3 November 2010.

  26. Arbelaez C, Wright EA, Losina E, et al. Emergency provider attitudes and barriers to universal HIV testing in the emergency department. J Emerg Med. 2010 (electronic publication ahead of print). Accessed 1 June 2010.

  27. Myers JJ, Modica C, Dufour M-K, Bernstein C, McNamara K. Routine rapid HIV screening in six community health centers serving populations at risk. J Gen Intern Med. 2009;24:1269–1274.

    Article  PubMed  Google Scholar 

  28. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2009 December 1, 2009:1-161. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 3 November 2010.

  29. Ho DD. Time to hit HIV, early and hard. N Engl J Med. 1995;333:450–451.

    Article  PubMed  CAS  Google Scholar 

  30. Henry K. The case for more cautious, patient-focused antiretroviral therapy. Ann Intern Med. 2000;132:306–311.

    PubMed  CAS  Google Scholar 

  31. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.

    Article  PubMed  Google Scholar 

  32. Kelley CF, Kitchen CMR, Hunt PW, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis. 2009;48:787–794.

    Article  PubMed  Google Scholar 

  33. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360:1815–1826.

    Article  PubMed  CAS  Google Scholar 

  34. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. The Lancet. 2009;373:1352-63.

  35. Manson JAE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523–534.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Sullivan was a Robert Wood Johnson Physician Faculty Scholar during the conduct of this study.

This update was presented at the meeting of the Society of General Internal Medicine on April 30, 2010.

Conflict of Interest

Dr. Cofrancesco has been a consultant for Gilead Sciences. No other disclosures.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amina A. Chaudhry MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaudhry, A.A., Berkenblit, G., Gifford, A.L. et al. Update in HIV Medicine for the Generalist. J GEN INTERN MED 26, 538–542 (2011). https://doi.org/10.1007/s11606-010-1580-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-010-1580-x

KEY WORDS

Navigation